Phophodiesterase-4 enzyme inhibitors as potential anti-inflammatory agents

Journal Title: Innovations in Pharmaceuticals and Pharmacotherapy (IPP) - Year 2015, Vol 3, Issue 2

Abstract

The Phosphodiesterases (PDEs) are a diverse family of enzymes that hydrolyze cyclic nucleotides such as cAMP & cGMP to the inactive 5’-AMP and 5’-GMP, respectively and thus play a key role in regulating intracellular levels of these second messengers and hence modulate cell functions which regulate a number of cellular processes such as metabolism, cell proliferation and differentiation, secretion, vascular and airway smooth muscle relaxation & the release of inflammatory mediators. The PDE superfamily contains 11 PDE isoenzymes (PDE1 to PDE11), which differ in primary structures, affinities for cAMP and cGMP, responses to specific effectors, sensitivities to specific inhibitors and mechanism of regulation. Each isoenzyme possesses at least one subtype. PDE4 has mainly four subtypes i.e. PDE4a, PDE4b, PDE4c, and PDE4d. The development of selective PDE4b inhibitors has not gained success till yet because of the structural similarity between the two isoforms of PDE4 i.e. PDE4b & PDE4d. Inhibition of PDE4b is responsible for the therapeutic effect while that of PDE4d for the side effects. The present review will be focused on the selective PDE4 enzyme inhibitors & their potential therapeutic utility

Authors and Affiliations

Amit Girdhar

Keywords

Related Articles

Study on prevalence of asthma and impact of pharmaceutical care in a clinical setting

Aim: Improvement in Asthma Control, Peak Expiratory Flow Rate (PEFR) and Asthma related Quality of Life Scores (AQLQ'S). Objectives: To document all the asthma cases admitted in the study department. To ascertain the kno...

Advanced injectable drug delivery system: A brief review

In modern therapeutics the controlled/sustained release dosage forms have become extremely popular. Development of sustained release injectable has occurred in the past few years. This was brought into existence to prolo...

Clinico-mycological spectrum of dermatophytoses in Chennai

Dermatophytes are common causes of skin, hair and nail infections and their clinic-mycological spectrum keeps changing with time and place. Aim: This prospective cross sectional study was conducted to analyse the clinica...

Advances and shortcoming of HIV/AIDS therapy

Increasing incidence of resistance of anti-tubercular drugs worldwide and the beginning of multi drug resistant in tuberculosis raise the need of new drugs for the treatment of tuberculosis and to understand the advances...

Thevetia peruviana: अश्वाघना: the Good Luck tree

This paper studied Thevetia peruviana, of the family Apocynaecae a plant that is native of North America and Mexico, that has been used as an anti-inflammatory, anti-microbial, and an anti-oxidant. The paper has made an...

Download PDF file
  • EP ID EP567653
  • DOI -
  • Views 102
  • Downloads 0

How To Cite

Amit Girdhar (2015). Phophodiesterase-4 enzyme inhibitors as potential anti-inflammatory agents. Innovations in Pharmaceuticals and Pharmacotherapy (IPP), 3(2), 565-579. https://europub.co.uk./articles/-A-567653